Improve cell counting accuracy. Learn how to use a hemocytometer and automated counters with human iPSC-derived cells using top tips from bit.bio experts.
03.08.2026
NAMs for DILI prediction: What’s driving the change?
Explore how NAMs are advancing DILI prediction in preclinical toxicology and why hepatic cell quality is key to improving liver sa...
iPSC-derived cells and the future of NAMs after FDA Modernization Act 2.0
Discover how the FDA Modernization Act 2.0 and human iPSCs are moving drug discovery beyond animal models to improve predictive va...
Mapping perturbation space: a transcription factor atlas across biological context
Read the blog to find out how perturbations shape cell identity at industrial scale.
Decision-making in drug development: A changing landscape
Discover how the FDA Modernization Act 2.0 and human iPSCs are moving drug discovery beyond animal models to improve predictive va...
Neuroscience 2025: The shift toward integrated human models
In this article, we recapitulate the highlights of SfN 2025.
Cell-based drug discovery: Why human iPSC-derived models are gaining ground
Explore how iPSC-derived models are transforming cell-based drug discovery with scalable, human-relevant assays that improve trans...
The power of expression data in rare disease research
In this article, we explore how easy access to gene expression data can help advance treatments for ultra-rare diseases.
Still using HMC3? Why labs are switching to hiPSC-derived microglia
HMC3 cells lack key microglial features. Learn why labs are switching to ioMicroglia—human iPSC-derived, functional, and consisten...